Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware

Bulletin Express01-22 12:02

Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.

The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.

The announcement is dated January 20, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment